North America Anatomic Pathology Market

North America Anatomic Pathology Market Size

The north america anatomic pathology market was valued at USD 8.15 billion in 2025, is estimated to grow at a CAGR of 5.51% during the forecast period, andise worth USD 13.2 billion by 2034 from USD 8.59 billion in 2026.

The growing patient population of chronic diseases across the North American region is majorly propelling the growth of the anatomic pathology market in North America.

As per the data published by the American Cancer Society, approximately 1.9 million new cancer cases were recorded in the U.S. in 2023. Anatomical pathology is used to study the abnormalities in the organ's structure and plays a vital role in the diagnosis of cancer. As a result, the growing incidence of diseases such as cancer is expected to result in the increased usage of anatomic pathology and contribute to regional market growth. The rising demand for personalized medicine across North America is further fuelling the growth rate of the North American anatomic pathology market. Personalized medicine is an approach developed based on the study of the patient's genes and blood tests,s and works effectively compared to generic medicine. Anatomic pathology helps in studying the cause of diseases and aids in the development of personalized medicine. In addition, the pathologist helps the healthcare provider make starting decisions, which helps with the patient's treatment.

The growing number of R&D efforts by medical device manufacturers to bring advanced medical devices and medical equipment to address the growing burden of various diseases is anticipated to favor the anatomic pathology market growth in North America. Advanced technologies such as artificial intelligence and machine learning are used in pathology studies, whichelpps reduce manual errors during the manufacturing process. The manufacturers of medical devices are interested in manufacturing devices that can be used to study and examine chronic diseases. Furthermore, the growing number of product launches, increasing number of mergers and acquisitions between the market participants, favorable reimbursement policies, and support from the governments of North American countries are fuelling regional market growth. On the other hand, the scarcity of skilled professionals, the lack of proper infrastructure facilities in the laboratories, the lack of accurate data for analysis, and the high cost of detection procedures majorly impede the anatomic pathology market growth in North America.

KEY MARKET PLAYERS

The North American Anatomy Pathology Market is exceptionally incoherent, and many big players exist in this region. Key Players of this market in the North American region include Thermo Fisher Scientific, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., Danaher Corporation, and Agilent Technologies.

MARKET SEGMENTATION

This research report on the North American anatomic pathology market has been segmented & sub-segmented into the following categories.

By Product

• Instruments
• Accessories

By End-User

• Diagnostics Lab
• Hospitals
• Physicians’ Office Lab

By Application

• Lymphoma
• Breast
• Lung
• Cervical
• Colorectal
• Prostate

By Country

• The United States
• Canada
• Rest of North America